Symbiotec Pharmalab IPO
Symbiotec Pharmalab Limited IPO – Price Band, Dates, Lot Size, Financials & Allotment Status
Symbiotec Pharmalab IPO Profile
Symbiotec Pharmalab Company Profile
Symbiotec Pharmalab Limited is a research and development-driven pharmaceutical and biotechnology company. The company operates across organic chemistry, biotechnology and complex injectable platforms.
The company is engaged in the development and manufacturing of active pharmaceutical ingredients (APIs), nutritional ingredients and specialty pharmaceutical products. It has a strong presence in international markets and focuses on science-based pharmaceutical manufacturing.
• Pharmaceutical and biotechnology focused company
• API and specialty product manufacturing
• Research & development driven business
• Presence across international markets
• Capabilities in organic chemistry, biotechnology and complex injectables
Symbiotec Pharmalab IPO Details
| Particulars | Details |
|---|---|
| Company Name | Symbiotec Pharmalab Limited |
| IPO Type | Mainboard IPO |
| Issue Type | Book Building |
| IPO Open | 24 August 2026 |
| IPO Close | 27 August 2026 |
| Price Band | ₹938 – ₹988 |
| Face Value | ₹2 per share |
| Market Lot | 15 Shares |
| Minimum Investment | ₹14,820 |
| Issue Size | ₹1,757 Crore |
| Fresh Issue | ₹150 Crore approx. |
| Offer for Sale | ₹1,607 Crore approx. |
| Listing | NSE & BSE |
| Basis of Allotment | 28 August 2026 |
| Listing Date | 01 September 2026 |
Symbiotec Pharmalab Financials
The following financial figures provide a quick overview of the company's revenue and profitability trend.
| Financial Year | Revenue (₹ Cr) | PAT (₹ Cr) | EBITDA (₹ Cr) |
|---|---|---|---|
| FY 2024 | 723.33 | 100.06 | 177.04 |
| FY 2025 | 755.98 | 96.79 | 206.11 |
| FY 2026 | 872.26 | 109.90 | 231.97 |
Note: Financial figures are presented for informational purposes and investors should refer to the IPO offer documents for detailed financial information.
Objectives of Symbiotec Pharmalab IPO
- Prepayment and/or repayment of certain outstanding borrowings.
- General corporate purposes.
- Strengthening the company's financial position.
Symbiotec Pharmalab IPO Allotment Status
Symbiotec Pharmalab IPO allotment is expected to be finalized on 28 August 2026. Investors can check their allotment status using PAN/Application Number or other details provided by the registrar.
Check IPO Allotment Status